Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Yangxin Formula in Enhanced Recovery After CABG
NCT07781436Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Qi-yin deficiency syndrome (QYDS) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Seattle Angina Questionnaire Score at 7 days. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
Qi-yin deficiency syndrome (QYDS)
Beyond the preview
Go deeper on NCT07781436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781436.